Compound ID | 3298
Class: Beta-lactam (cephalosporin) + beta-lactamase inhibitor
Spectrum of activity: | Gram-positive |
Details of activity: | Active against Enterobacterales expressing serine beta-lactamases |
Combined with other compounds: | Yes |
Description: | Synthetic compound; drug combination; cephalosporin-type beta-lactam |
Year first mentioned: | 2022 |
Highest developmental phase: | Phase 1 |
Development status: | Experimental |
Chemical structure(s): | |||||||||||
|
|